SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-20-011340
Filing Date
2020-05-29
Accepted
2020-05-29 16:12:55
Documents
1
Period of Report
2020-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3238
  Complete submission text file 0001567619-20-011340.txt   4553
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address
ANDERSON ELIZABETH M (Reporting) CIK: 0001758247 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 20927861